Terms: = Uterine cancer AND FOXP3, AIID, DIETER, IPEX, JM2, PIDX, XPID AND Prognosis
28 results:
1. Prognostic Impact of Tumor-Infiltrating Lymphocytes, Tertiary Lymphoid Structures, and Neutrophil-to-Lymphocyte Ratio in Pulmonary Metastases from uterine Leiomyosarcoma.
Matsuda N; Yamamoto H; Habu T; Iwata K; Matsubara K; Tanaka S; Hashimoto K; Shien K; Suzawa K; Miyoshi K; Toji T; Okazaki M; Sugimoto S; Takahashi K; Toyooka S
Ann Surg Oncol; 2023 Dec; 30(13):8727-8734. PubMed ID: 37658268
[TBL] [Abstract] [Full Text] [Related]
2. Brachytherapy for targeting the immune system in cervical cancer patients.
Linares I; Berenguer Frances MÁ; Cañas R; Najjari D; Gutiérrez C; Marín S; Comas S; Guedea F; Pujol M
BMC Immunol; 2023 Aug; 24(1):23. PubMed ID: 37559025
[TBL] [Abstract] [Full Text] [Related]
3. Infection pattern and immunological characteristics of Epstein-Barr virus latent infection in cervical squamous cell carcinoma.
Zuo Y; Xiao H; Lv D; Huang M; Wang L; Liu J; Zhang K; Shen J; Wang Z; Wu Q; Xu Y
J Med Virol; 2023 Apr; 95(4):e28717. PubMed ID: 37184049
[TBL] [Abstract] [Full Text] [Related]
4. Tumor Microenvironment CD8 T and Treg Cells-related Genes Signature Distinguishes Distinct prognosis and Targeted Therapies Response in Endometrial cancer.
Liu X; Feng D; Wang W; Liang J; Yu H; Ling B
J Immunother; 2023 Jun; 46(5):178-191. PubMed ID: 37098928
[TBL] [Abstract] [Full Text] [Related]
5. Predictive value of an exosomal microRNA-based signature for tumor immunity in cervical cancer patients treated with chemoradiotherapy.
Someya M; Hasegawa T; Tsuchiya T; Kitagawa M; Fukushima Y; Gocho T; Mafune S; Ikeuchi Y; Kozuka Y; Idogawa M; Hirohashi Y; Torigoe T; Iwasaki M; Matsuura M; Saito T; Sakata KI
Med Mol Morphol; 2023 Mar; 56(1):38-45. PubMed ID: 36367588
[TBL] [Abstract] [Full Text] [Related]
6. The association between the tumor immune microenvironments and clinical outcome in low-grade, early-stage endometrial cancer patients.
López-Janeiro Á; Villalba-Esparza M; Brizzi ME; Jiménez-Sánchez D; Ruz-Caracuel I; Kadioglu E; Masetto I; Goubert V; Garcia-Ros D; Melero I; Peláez-García A; Hardisson D; de Andrea CE
J Pathol; 2022 Dec; 258(4):426-436. PubMed ID: 36169332
[TBL] [Abstract] [Full Text] [Related]
7. Identification and validation of TNFRSF4 as a high-profile biomarker for prognosis and immunomodulation in endometrial carcinoma.
Ma H; Feng PH; Yu SN; Lu ZH; Yu Q; Chen J
BMC Cancer; 2022 May; 22(1):543. PubMed ID: 35562682
[TBL] [Abstract] [Full Text] [Related]
8. Genetic association study of intron variants in the forkhead box protein P3 gene in Chinese patients diagnosed with cervical cancer.
Shi F; Pang XX; Li GJ; Chen ZH; Dong MY; Wang JL
J Cell Mol Med; 2022 May; 26(9):2658-2672. PubMed ID: 35322929
[TBL] [Abstract] [Full Text] [Related]
9. Identification of an immune-related risk signature and nomogram predicting the overall survival in patients with endometrial cancer.
Cheng Y; Li X; Dai Y; Dong Y; Yang X; Wang J
J Gynecol Oncol; 2021 May; 32(3):e30. PubMed ID: 33559412
[TBL] [Abstract] [Full Text] [Related]
10. Molecular phenotype of high-grade endometrioid carcinoma of the endometrium.
Buchynska LG; Glushchenko NM; Nesina IP; Brieieva OV; Iurchenko NP
Exp Oncol; 2020 Dec; 42(4):300-305. PubMed ID: 33355863
[TBL] [Abstract] [Full Text] [Related]
11. Infiltrating T-cell markers in cervical carcinogenesis: a systematic review and meta-analysis.
Litwin TR; Irvin SR; Chornock RL; Sahasrabuddhe VV; Stanley M; Wentzensen N
Br J Cancer; 2021 Feb; 124(4):831-841. PubMed ID: 33257839
[TBL] [Abstract] [Full Text] [Related]
12. Tissue Infiltrating Immune Cells as Prognostic Biomarkers in Endometrial cancer: A Meta-Analysis.
Guo F; Dong Y; Tan Q; Kong J; Yu B
Dis Markers; 2020; 2020():1805764. PubMed ID: 32076456
[TBL] [Abstract] [Full Text] [Related]
13. Distinct Immunological Landscapes Characterize Inherited and Sporadic Mismatch Repair Deficient Endometrial cancer.
Ramchander NC; Ryan NAJ; Walker TDJ; Harries L; Bolton J; Bosse T; Evans DG; Crosbie EJ
Front Immunol; 2019; 10():3023. PubMed ID: 31998307
[TBL] [Abstract] [Full Text] [Related]
14. Evaluation of PTEN and CD4+foxp3+ T cell expressions as diagnostic and predictive factors in endometrial cancer: A case control study.
Xi Z; Jing L; Le-Ni K; Zhu L; Ze-Wen D; Hui Y; Ming-Rong X; Guang-Dong L
Medicine (Baltimore); 2019 Jul; 98(30):e16345. PubMed ID: 31348233
[TBL] [Abstract] [Full Text] [Related]
15. Role of B7-H4 in the Progression and prognosis of Cervical Inflammation to cancer After Human Papilloma Virus Infection.
Qiu F; Yuan C; Xu J; Zhang J; Chen F; Liu D; Zheng B; Li R; Huang X; Xu J
J Biomed Nanotechnol; 2019 May; 15(5):1043-1051. PubMed ID: 30890234
[TBL] [Abstract] [Full Text] [Related]
16. CD8, foxp3, and CD45RO+ Lymphocytic Infiltrates in Type I and Type II Endometrial cancers in African American and European American Females.
Rashid T; Young-Pierce JL; Garrett-Mayer E; Graybill W; Neal S; Spruill LS
Int J Gynecol Pathol; 2017 Nov; 36(6):540-549. PubMed ID: 28114190
[TBL] [Abstract] [Full Text] [Related]
17. The expression of foxp3 and TLR4 in cervical cancer: association with immune escape and clinical pathology.
Zhang H; Zhang S
Arch Gynecol Obstet; 2017 Mar; 295(3):705-712. PubMed ID: 28013346
[TBL] [Abstract] [Full Text] [Related]
18. CD103 defines intraepithelial CD8+ PD1+ tumour-infiltrating lymphocytes of prognostic significance in endometrial adenocarcinoma.
Workel HH; Komdeur FL; Wouters MC; Plat A; Klip HG; Eggink FA; Wisman GB; Arts HJ; Oonk MH; Mourits MJ; Yigit R; Versluis M; Duiker EW; Hollema H; de Bruyn M; Nijman HW
Eur J Cancer; 2016 Jun; 60():1-11. PubMed ID: 27038842
[TBL] [Abstract] [Full Text] [Related]
19. Roles of foxp3 in the occurrence and development of cervical cancer.
Luo Q; Zhang S; Wei H; Pang X; Zhang H
Int J Clin Exp Pathol; 2015; 8(8):8717-30. PubMed ID: 26464616
[TBL] [Abstract] [Full Text] [Related]
20. Correlations between immune response and vascularization qRT-PCR gene expression clusters in squamous cervical cancer.
Punt S; Houwing-Duistermaat JJ; Schulkens IA; Thijssen VL; Osse EM; de Kroon CD; Griffioen AW; Fleuren GJ; Gorter A; Jordanova ES
Mol Cancer; 2015 Mar; 14():71. PubMed ID: 25889974
[TBL] [Abstract] [Full Text] [Related]
[Next]
